Andrew Farquharson

Andrew is an investor and entrepreneur with two decades of success shaping and building companies in life sciences. The co-founder of VentureHealth and InCube Ventures, his passion is biomedical innovation that dramatically improves lives.

Prior to becoming a professional investor, Andrew helped to build Operon Technologies into the world’s most successful DNA synthesis company by launching the world’s first whole-genome tools for interrogating the malaria and tuberculosis genomes. He and his partner sold that business to QIAGEN, where he became a member of the senior executive team, leading M&A. He began his career at Genentech, where he led teams in various operational and research roles.

Andrew holds a Masters of Business Administration from Harvard University and a Bachelor’s with high honors from the University of California at Berkeley.